Results 181 to 190 of about 326,550 (210)

Gene Expression in Urinary Sediment Cells as an Indicator of the Contribution of Plasma Lipids to Diabetic Kidney Disease. [PDF]

J Diabetes Res
Zocchio TT, Santos AS, Cavaleiro AM, Matheus LHG, de Fátima Mello Santana M, Palanca E, Rodrigues AT, Vancini MG, Nery M, Passarelli M, Corrêa-Giannella ML.   +10 more
europepmc   +1 more source

Association Between DNA Methylation of <i>MTHFR</i> and Diabetic Kidney Disease. [PDF]

J Diabetes Res
Deng G, Feng Z, Kong X, Gao P, Jiang Y, Liu Y, Zhao M, Ma L.   +7 more
europepmc   +1 more source

LncRNA ENST00000532153.1 alleviates podocyte injury by inhibiting PARP1-mediated PARylation of ATF3 in diabetic kidney disease. [PDF]

Cell Mol Life Sci
Yu Q, Yang M, Lu S, Su H, Liu Y, Zhang X, Fan X, Lv Z, Wang R.   +8 more
europepmc   +1 more source

Mechanism of <i>Rhizoma Chuanxiong</i> for the treatment of diabetic kidney disease based on network pharmacology. [PDF]

Ren Fail
Yan Y, Shi H, Li Y, Wan X, Li J, Wang L.
europepmc   +1 more source

Impact of optimal anti-proteinuric therapy on the prevention of diabetic kidney disease progression. [PDF]

Sci Rep
Ismail SA, Kebede MA, Wondafrash G, Ambachew R, Abdi RA, Ahmed ET, Belete MW, Eshetu MA, Yesuf SA.   +8 more
europepmc   +1 more source

Macrophage Derived Galectin-3 Promotes Renal Fibrosis and Diabetic Kidney Disease by Enhancing TGFβ1 Signaling. [PDF]

Adv Sci (Weinh)
Chen Y, Jiang Q, Xing X, Xu L, Zhao Q, Zhang Q, Chen J, Ma C, Liu X, Lu Y, Wan Y, Kong L, Hou S, Lu Q, Cui B, Guo J, Huang H, Li P.   +17 more
europepmc   +1 more source

Accelerated biological aging and homeostatic dysregulation in diabetic kidney disease: Evidence from NHANES and Mendelian randomization. [PDF]

Medicine (Baltimore)
Wang D, Ren K, Zhu Z, Lv Y, Jin H, Zhang L, Wang Y.   +6 more
europepmc   +1 more source

Prostaglandins supplementation enhances the efficacy of standard care on renal outcomes in patients with diabetic kidney disease. [PDF]

Chin Med J (Engl)
Gu X, Zhang D, Jiang S, Liu L, Li W.
europepmc   +1 more source

Adropin as a Marker in Type 2 Diabetes: Insights Into Diabetic Kidney Disease and Chronic Heart Failure. [PDF]

Cureus
Sonkar SK, Agrawal M, Sonkar GK, Bhosale V, Gautam M, Pradhan A, Kumar S, Bhagchandani D, Singh A.   +8 more
europepmc   +1 more source

Therapeutic potential of natural medicines in diabetic kidney disease: restoring lipid homeostasis via lipophagy modulation. [PDF]

Front Pharmacol
Gao J, Wu Y, Cai X, Zhao H, Xing J.
europepmc   +1 more source